Biological conditions influencing the focal necrotic hepatitis test for differentiation between herpes simplex virus types 1 and 2
- PMID: 187007
Biological conditions influencing the focal necrotic hepatitis test for differentiation between herpes simplex virus types 1 and 2
Abstract
Some biological conditions of the focal necrotic hepatitis test for the differentiation between herpes simplex virus (HSV) types 1 and 2 were investigated. Most of 13 different strains of mice tested were found usable in the test. An upper age limit (4 weeks) for the appearance of focal necrotic liver lesions was found in one strain of mice, while this was not seen in another strain. The minimum dose in 3- to 4-week-old mice was found to be as small as 10(2) to 10(3) p.f.u. in 0.1 ml of diluent. Suckling rats and hamsters, aged up to 7 and 14 days, respectively, were found to be convenient as alternative test animals. Finally, it was observed that focal necrotic hepatitis did not develop in the nude mouse with thymic aplasia on intraperitoneal inoculation of HSV type 2. The possible involvement of the thymus in the pathogenesis of the focal necrotic lesions is briefly discussed.
Similar articles
-
NTP Technical Report on the comparative toxicity studies of allyl acetate (CAS No. 591-87-7), allyl alcohol (CAS No. 107-18-6) and acrolein (CAS No. 107-02-8) administered by gavage to F344/N rats and B6C3F1 mice.Toxic Rep Ser. 2006 Jul;(48):1-73, A1-H10. Toxic Rep Ser. 2006. PMID: 17160105
-
Spread of HSV and establishment of latency after corneal infection in inbred mice.Invest Ophthalmol Vis Sci. 1986 Jan;27(1):77-82. Invest Ophthalmol Vis Sci. 1986. PMID: 3000975
-
Herpes simplex virus hepatitis in mice: effects of treatment with trisodium phosphonoformate.Acta Virol. 1985 Dec;29(6):493-8. Acta Virol. 1985. PMID: 2869661
-
Nonneutralizing antibody against the glycoprotein K of herpes simplex virus type-1 exacerbates herpes simplex virus type-1-induced corneal scarring in various virus-mouse strain combinations.Invest Ophthalmol Vis Sci. 1997 May;38(6):1213-21. Invest Ophthalmol Vis Sci. 1997. PMID: 9152241
-
Herpes simplex virus brainstem encephalitis in an AIDS patient.Clin Neuropathol. 1995 Jan-Feb;14(1):45-50. Clin Neuropathol. 1995. PMID: 7729081
Cited by
-
Role of activated macrophages in resistance of congenitally athymic nude mice to hepatitis induced by herpes simplex virus type 2.Infect Immun. 1978 Mar;19(3):792-8. doi: 10.1128/iai.19.3.792-798.1978. Infect Immun. 1978. PMID: 205507 Free PMC article.
-
Effect of silica on the pathogenic distinction between herpes simplex virus type 1 and 2 hepatitis in mice.Infect Immun. 1977 Aug;17(2):274-7. doi: 10.1128/iai.17.2.274-277.1977. Infect Immun. 1977. PMID: 197016 Free PMC article.
-
X-linked resistance of mice to high doses of herpes simplex virus type 2 correlates with early interferon production.Infect Immun. 1983 Nov;42(2):740-6. doi: 10.1128/iai.42.2.740-746.1983. Infect Immun. 1983. PMID: 6196293 Free PMC article.
-
Increased efficacy of phosphonoformate and phosphonoacetate inhibition of herpes simplex virus type 2 replication by encapsulation in liposomes.Antimicrob Agents Chemother. 1988 Jun;32(6):858-64. doi: 10.1128/AAC.32.6.858. Antimicrob Agents Chemother. 1988. PMID: 2843083 Free PMC article.
-
Role of macrophages in hepatitis induced by Herpes simplex virus types 1 and 2 in mice.Infect Immun. 1977 Mar;15(3):686-91. doi: 10.1128/iai.15.3.686-691.1977. Infect Immun. 1977. PMID: 192671 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources